Načítá se...
Clinical utility of pharmacogenomics in the management of hepatitis C
Hepatitis C virus (HCV) was identified for the first time more than 20 years ago. Since then, several studies have highlighted the complicated aspects of this viral infection in relation to its worldwide prevalence, its clinical presentation, and its therapeutic response. Recently, two landmark scie...
Uloženo v:
| Vydáno v: | Pharmgenomics Pers Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4222698/ https://ncbi.nlm.nih.gov/pubmed/25382982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S52624 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|